Zika virus (ZIKV), so-called because it was originally isolated from a rhesus monkey in the Zika Forest, Uganda, in 1947 ([@B6]), is a flavivirus transmitted to people mainly through the bite of an infected *Aedes* sp. mosquito (*A. aegypti* or *A. albopictus*). *Aedes* spp. mosquitoes that transmit also dengue, chikungunya, and yellow fever occur worldwide, and constitute a high risk for ZIKV global transmission. ZIKV infection is usually asymptomatic or causes mild symptoms, such as fever, rash, muscle/joint pain and conjunctivitis. Severe disease and fatalities are uncommon ([@B14]). Infections in humans have occurred in several African and Asian countries. In 2007, an outbreak of ZIKV on Yap Island in the southwestern Pacific Ocean started as a relatively mild disease characterised by rash, arthralgia and conjunctivitis. This was the first time that ZIKV was detected outside of Africa or Asia ([@B7], [@B9]. In October 2013, French Polynesia recorded a large outbreak with a great number of cases, some of which presented neurological and autoimmune complications (Guillain-Barre syndrome). The clinical presentation is defined as a "dengue-like syndrome" ([@B13].

In early 2015, ZIKV was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in the sera of eight patients from the Brazilian northeastern region, who presented symptoms of mild fever, rash, conjunctivitis and arthralgia ([@B23]). In addition, other symptoms have been observed that include microcephaly in newborns apparently resulting from ZIKV infection of the mothers during pregnancy ([@B10]). ZIKV currently circulates in 21 Brazilian states and is estimated to have infected between 440,000 to 1.3 million people in 2015. As of May 7, 2016, 7438 cases of microcephaly have been reported according to the surveillance protocol settings (newborn, stillbirth, abortion, or fetus). Of these suspected cases, 4004 cases were investigated and classified, whereas 3433 (46.2%) remain under investigation. Of the classified cases, 1326 were confirmed for microcephaly and/or central nervous system abnormalities suggestive of congenital infection and 2679 were discarded ([@B22], [@B16]). Studies performed by Slovenian researchers ([@B15]) have detected ZIKV in microcephalic foetal brain tissue by real time RT-PCR. This finding was also consistent with electron microscopy observations. Furthermore, the complete genome of ZIKV was recovered from the foetal brain. The expectant mother had a febrile illness with rash at the end of the first trimester of pregnancy while she was living in Brazil. Since Brazil reported ZIKV in May 2015, infections have occurred in at least 20 countries, mainly in South and Central America. The Pan American Health Organization issued a series of epidemiological updates and alerts in 2015 urging for enhanced surveillance of ZIKV as well as for neurological, autoimmune and congenital malformation associations ([@B17], [@B14]).

Monolayers of Vero cells were inoculated with a blood sample from a ZIKV positive patient and analysed for the presence of ZIKV particles by transmission electron microscopy (TEM). The supernatants of the infected cells were tested by real time RT-PCR for the presence of ZIKV genomes.

The blood sample used was obtained from a patient residing in Vitória, Espiríto Santo, Brazil, in July 2015 and who presented with fever, myalgia, arthralgia, nausea, pruriginous exanthema as well as joint pain in the hands and feet. ZIKV was first isolated from the patient's blood sample in the *A. albopictus* C6/36 cell line and then propagated in Vero cells. Vero cells were inoculated with 200 mL of C6/36 fluid that was adsorbed onto the cells for 1 h at 37ºC. After the incubation period, Minimum Essential Medium Eagle (MEM) supplemented with 2% foetal bovine serum was added and the cells were incubated at 37ºC. Six days after inoculation, the cell culture fluid was used for molecular analysis and the cell monolayer was processed for morphological analysis.

*Molecular analysis* - Vero cell culture fluid was subjected to quantitative ZIKV-specific real time RT-PCR ([@B12] *).* Viral RNA was extracted from 140 μL of the culture fluid using the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA) in accordance with the manufacturer's suggested protocol.

*Morphological analysis* - Cells were fixed with 1% glutaraldehyde in sodium cacodylate buffer (0.2 M, pH 7.2), post-fixed with 1% buffered osmium tetroxide, dehydrated in acetone, embedded in epoxy resin, and polymerised at 60ºC for three days ([@B19], [@B1], [@B2]). The resin blocks were then cut into 50-70 nm thick ultrathin sections. The sections were picked up on copper grids, stained with uranyl acetate and lead citrate, and observed in a Zeiss EM-900 TEM.

Ultrastructural analysis by transmission electron microscopy showed injury of Vero cell monolayers six days post-inoculation with ZIKV. Numerous myelin figures, vacuoles and mitochondria filled the cytoplasm. Viral particles of approximately 50 nm in diameter occurred as clusters inside vesicles ([Fig. 1A-B](#f01){ref-type="fig"}). Viral nucleocapsids were also observed ([Fig. 1C](#f01){ref-type="fig"}). Furthermore, viral RNA in the supernatants from the inoculated cell monolayers was detected by real time RT-PCR, confirming the presence of ZIKV.

Vero cells six days post inoculation with a human blood serum sample positive for ZIKV. (A) Infected Vero cell presenting numerous myelin figures (\*), vacuoles, and clusters of ZIKV particles (marked areas); bar = 700 nm; (B) ZIKV particles (arrows); bar = 120 nm; (C) regularly arranged viral nucleocapsids (arrow head); bar = 300 nm.

Vero cells are widely used in virology studies for their efficiency in replicating several viruses such as measles, poxviruses, dengue and rubeola ([@B21], [@B3], [@B18]). In the present study, Vero cell cultures that were inoculated with a ZIKV positive human blood sample showed clusters of viral particles inside cytoplasmic vesicles. The diameter of these virus particles averaged 50 nm. Besides enveloped virus particles, nucleocapsids were also observed indicating that viral replication occurred. Replication of the virus was further confirmed by real time RT-PCR. These aspects confer with the morphological studies of dengue virus replication in C6/36 and Vero cells ([@B3]).

The presence of ZIKV genomes in cultures of Vero cells was also confirmed by [@B4] using real time RT-PCR, thus corroborating ultrastructural observations made by transmission electron microscopy.

ZIKV proteins were detected by immunohistochemistry in human placental tissue (de [@B5]). ZIKV particles were observed in cells from microcephalic foetal brain tissue ([@B15]) that were formerly detected by real time RT-PCR. The viral particles showed typical flavivirus features and were 50-57 nm in diameter. In addition, the cryo-electron microscopy structure of ZIKV particles presented a 50 nm diameter ([@B11], [@B20]). Experimentally infected human neural stem cells with ZIKV showed a typical flavivirus configuration ([@B8]).

To date, the data presented on the morphological features of ZIKV particles in tissues and cell cultures are consistent.
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